Antibodies is an international, peer-reviewed, open access journal on immunoglobulins, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and many other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 22.6 days after submission; acceptance to publication is undertaken in 5.9 days (median values for papers published in this journal in the second half of 2021).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Antibodies, Cancers, Immuno, IJMS, Vaccines
Anti-Tumor Immune Responses Topic Editors: Massimo Zollo, Erle S. Robertson, Renata Grifantini
Deadline: 14 October 2022
Special Issue in Antibodies
Antibody Drug and Target Discovery for Cancer Therapies Guest Editor: Nicolas Bery
Deadline: 15 June 2022
Special Issue in Antibodies
Women's Special Issue Series: Recent Development for Improved Therapeutic Antibodies Guest Editor: Josee Golay
Deadline: 30 June 2022
Special Issue in Antibodies
Advances in the Use of Therapeutic Antibodies and Identification of Novel Autoantibodies in Dermatologic Disease Guest Editor: Kyle T. Amber
Deadline: 15 July 2022
Special Issue in Antibodies
Phage and Ribosome Display for Antibody Discovery and Optimization Guest Editor: Adinarayana Kunamneni
Deadline: 31 July 2022
Topical Collection in Antibodies
Computational Antibody and Antigen Design Collection Editor: Buyong Ma
Back to TopTop